Drugs / Infusion of recipient T regulatory cell
Infusion of recipient T regulatory cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05973734 | Apr 2024 → Dec 2030 expected | — | Stanford University | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infusion of recipient T regulatory cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05973734 ↗ |
| Modality | Cell therapy | “their own immune cells, called regulatory T cells” NCT05973734 ↗ |
| Route | Other | “the collected cells used as the source of purified Tregs to be infused following the islet transplantation” NCT05973734 ↗ |